tantum rosa 500 mg
a.c.r.a.f. s.p.a. - italia - benzydaminum - gran. pt. sol. vaginala - 500mg - alte preparate ginecologice med. antiinflam. pt. adm. vaginala
tantum rosa 500 mg granule pentru soluţie vaginală
aziende chimiche riunite angelini francesco acraf s.p.a. - benzydaminum - granule pentru soluţie vaginală - 500 mg
tantum rosa 1 mg/ml soluţie vaginală
aziende chimiche riunite angelini francesco acraf s.p.a. - benzydaminum - soluţie vaginală - 1 mg/ml
tantum rosa 1 mg/ml
aziende chimiche riunite a.f. s.p.a.-acraf s.p.a. - italia - benzydaminum - sol. vaginala - 1 mg/ml - alte medicamente ginecologice med. antiinflam. pt. adm. vaginala
tantum rosa solutie vaginala 0,1%
aziende chimiche riunite angelini francesco acraf s.p.a. - solutie vaginala - 0,1%
tantum rosa pulbere pentru solutie vaginala 500 mg
aziende chimiche riunite angelini francesco acraf s.p.a. - pulbere pentru solutie vaginala - 500 mg
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
biobos rcc
bioveta a.s., republica cehă - rotavirus bovin, tulpina tm-91, serotip g6p1, coronavirus bovin, tulpina c-197, e. coli inactivat care exprimă adhesin f5 (k99), tulpina o8:k35 - suspensie injectabilă - produse biologice - bovine - bovine (juninci și vaci gestante) imunizarea activă a junincilor și vacilor gestante pentru a stimula producerea de anticorpi impotriva rotavirusului bovin, coronavirusului bovin și e. coli care exprimă adhesin f5 (k99) și pentru a crește nivelul imunității pasive a vițeilor împotriva diareei neonatale cauzate de rotavirusul bovin, coronavirusul bovin și e. coli care exprimă adhesin f5 (k99).
bicard-lf comprimate filmate 10 mg
lekpharm srl - bisoprololum - comprimate filmate - 10 mg